Abstract:We have developed a robust, nanobiotechnology-based electrochemical cytosensing approach with high sensitivity, selectivity, and reproducibility toward the simultaneous multiplex detection and classification of both acute myeloid leukemia and acute lymphocytic leukemia cells. The construction of the electrochemical cytosensor involves the hierarchical assembly of dual aptamer-functionalized, multilayered graphene-Au nanoparticle electrode interface and the utilization of hybrid electrochemical nanoprobes co-functionalized with redox tags, horseradish peroxidase, and cell-targeting nucleic acid aptamers. The hybrid nanoprobes are multifunctional, capable of specifically targeting the cells of interest, amplifying the electrochemical signals, and generating distinguishable signals for multiplex cytosensing. The as-assembled electrode interface not only greatly facilitates the interfacial electron transfer process due to its high conductivity and surface area but also exhibits excellent biocompatibility and specificity for cell recognition and adhesion. A superstructured sandwich-type sensor geometry is adopted for electrochemical cytosensing, with the cells of interest sandwiched between the nanoprobes and the electrode interface. Such an electrochemical sensing strategy allows for ultrasensitive, multiplex acute leukemia cytosensing with a detection limit as low as similar to 350 cells per mL and a wide linear response range from 5 x 10(2) to 1 x 10(7) cells per mL for HL-60 and CEM cells, with minimal cross-reactivity and interference from non-targeting cells. This electrochemical cytosensing approach holds great promise as a new point-of-care diagnostic tool for early detection and classification of human acute leukemia and may be readily expanded to multiplex cytosensing of other cancer cells.

Ultrasensitive self-powered cytosensor

Light-driven ultrasensitive self-powered cytosensing of circulating tumor cells via integration of biofuel cells and a photoelectrochemical strategy

An efficient nanomaterial-based electrochemical biosensor for sensitive recognition of drug-resistant leukemia cells.

(Invited) Nanoparticles Based Electrochemical Biosensors for the Detection of Tumor Cells and Associated Biomarkers

Carbon Nanotube-Bilirubin Oxidase Bioconjugate As a New Biofuel Cell Label for Self-Powered Immunosensor.

Multiplex acute leukemia cytosensing using multifunctional hybrid electrochemical nanoprobes at a hierarchically nanoarchitectured electrode interface.

Renewable photoelectrochemical cytosensing platform for rapid capture and detection of circulating tumor cells

Ultrasensitive Self-Powered Cytosensors Based on Exogenous Redox-Free Enzyme Biofuel Cells As Point-of-care Tools for Early Cancer Diagnosis.

A Novel Ultrasensitive Competition Strategy for Electrochemical and Colorimetric Cytosensing of Acute Leukemia Cells

A Novel Aptamer-Based Competition Strategy for Ultrasensitive Electrochemical Detection of Leukemia Cells.

An integrated electrochemical immunosensor based on Pd-Ir cubic nanozyme and Ketjen black for ultrasensitive detection of circulating tumor cells

An integrated microfluidic cytosensor coupled with self-calibration electrochemical/colorimetric dual-signal output for sensitive and accurate detection of hepatoma cells

Ultrasensitive Capture, Detection, and Release of Circulating Tumor Cells Using a Nanochannel-Ion Channel Hybrid Coupled with Electrochemical Detection Technique.

Bifunctional electrochemical biosensor based on PB-MXene films for the real-time analysis and detection of living cancer cells

ECL cytosensor for sensitive and label-free detection of circulating tumor cells based on hierarchical flower-like gold microstructures

Ultrasensitive detection of cancer cells and glycan expression profiling based on a multivalent recognition and alkaline phosphatase-responsive electrogenerated chemiluminescence biosensor.

Direct Plasmon-Enhanced Electrochemistry for Enabling Ultrasensitive and Label-Free Detection of Circulating Tumor Cells in Blood.

Electrochemical Aptasensor for Ultralow Fouling Cancer Cell Quantification in Complex Biological Media Based on Designed Branched Peptides

Enhancing circulating tumor cell capture: Amin-functionalized bilayer graphene biosensing with integrated chip-level system for point-of-care testing

Temporal Sensing Platform Based on Bipolar Electrode for the Ultrasensitive Detection of Cancer Cells.

WITHDRAWN: Novel cytosensor for accurate detection of circulating tumor cells based on a dual-recognition strategy and BSA@Ag@Ir metallic-organic nanoclusters